Lee SC - Search Results

1

LMTK3 confers chemo-resistance in breast cancer.

Stebbing J, Shah K, Lit LC, Gagliano T, Ditsiou A, Wang T, Wendler F, Simon T, Szabó KS, O'Hanlon T, Dean M, Roslani AC, Cheah SH, Lee SC, Giamas G. Stebbing J, et al. Among authors: lee sc. Oncogene. 2018 Jun;37(23):3113-3130. doi: 10.1038/s41388-018-0197-0. Epub 2018 Mar 15. Oncogene. 2018. PMID: 29540829 Free PMC article.

2

LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome.

Stebbing J, Filipovic A, Ellis IO, Green AR, D'Silva TR, Lenz HJ, Coombes RC, Wang T, Lee SC, Giamas G. Stebbing J, et al. Among authors: lee sc. Breast Cancer Res Treat. 2012 Apr;132(2):537-44. doi: 10.1007/s10549-011-1622-z. Epub 2011 Jun 14. Breast Cancer Res Treat. 2012. PMID: 21671015

3

Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway.

Wang T, Seah S, Loh X, Chan CW, Hartman M, Goh BC, Lee SC. Wang T, et al. Among authors: lee sc. Oncotarget. 2016 Jan 19;7(3):2532-44. doi: 10.18632/oncotarget.6304. Oncotarget. 2016. PMID: 26565813 Free PMC article.

4

High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer.

Wang T, Srivastava S, Hartman M, Buhari SA, Chan CW, Iau P, Khin LW, Wong A, Tan SH, Goh BC, Lee SC. Wang T, et al. Among authors: lee sc. Oncotarget. 2016 Aug 23;7(34):55155-55168. doi: 10.18632/oncotarget.10894. Oncotarget. 2016. PMID: 27487140 Free PMC article.

5

PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression.

Gagliano T, Shah K, Gargani S, Lao L, Alsaleem M, Chen J, Ntafis V, Huang P, Ditsiou A, Vella V, Yadav K, Bienkowska K, Bresciani G, Kang K, Li L, Carter P, Benstead-Hume G, O'Hanlon T, Dean M, Pearl FM, Lee SC, Rakha EA, Green AR, Kontoyiannis DL, Song E, Stebbing J, Giamas G. Gagliano T, et al. Among authors: lee sc. J Clin Invest. 2020 Jun 1;130(6):3188-3204. doi: 10.1172/JCI128313. J Clin Invest. 2020. PMID: 32125284 Free PMC article.

6

Clinical implications of chemotherapy-induced tumor gene expression in human breast cancers.

Tan SH, Lee SC. Tan SH, et al. Among authors: lee sc. Expert Opin Drug Metab Toxicol. 2010 Mar;6(3):283-306. doi: 10.1517/17425250903510611. Expert Opin Drug Metab Toxicol. 2010. PMID: 20163320 Review.

7

Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients.

Wong AL, Yap HL, Yeo WL, Soong R, Ng SS, Wang LZ, Cordero MT, Yong WP, Goh BC, Lee SC. Wong AL, et al. Among authors: lee sc. Cancer Genomics Proteomics. 2011 Sep-Oct;8(5):255-9. Cancer Genomics Proteomics. 2011. PMID: 21980041

8

An update on chemotherapy and tumor gene expression profiles in breast cancer.

Tan SH, Lee SC. Tan SH, et al. Among authors: lee sc. Expert Opin Drug Metab Toxicol. 2012 Sep;8(9):1083-113. doi: 10.1517/17425255.2012.694867. Epub 2012 Jun 11. Expert Opin Drug Metab Toxicol. 2012. PMID: 22681410 Review.

9

Understanding intra-tumour heterogeneity - the next holy grail of cancer therapeutics?

Lim JS, Lee SC. Lim JS, et al. Among authors: lee sc. Ann Acad Med Singap. 2014 Feb;43(2):72-3. Ann Acad Med Singap. 2014. PMID: 24652425 Free article. No abstract available.

10

High-Throughput Mutation Profiling Changes before and 3 Weeks after Chemotherapy in Newly Diagnosed Breast Cancer Patients.

Tan SH, Sapari NS, Miao H, Hartman M, Loh M, Chng WJ, Iau P, Buhari SA, Soong R, Lee SC. Tan SH, et al. Among authors: lee sc. PLoS One. 2015 Dec 2;10(12):e0142466. doi: 10.1371/journal.pone.0142466. eCollection 2015. PLoS One. 2015. PMID: 26630576 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,904 results

Search Page